Session XIII: Cellular Therapy 

Session Chairs: Rayne H. Rouce, MD, BS and Betul Oran, MD

Debate: Should We Transplant TP53 Mutated AML – PRO | Betul Oran, MD | MD Anderson Cancer Center, Houston, Texas, USA

Debate: Should We Transplant TP53 Mutated AML – CON | Mariam Nawas, MD | University of Chicago, Chicago, Illinois, USA

Debate: In Pediatric ALL Will There Still Be a Role for Allo SCT - PRO | Michael Pulsipher, MD | Huntsman Cancer Institute, Salt Lake City, Utah, USA

Debate: In Pediatric ALL Will There Still Be a Role for Allo SCT - CON | Rayne H. Rouce, MD | Baylor College of Medicine, Houston, Texas, USA

Follicular Lymphoma Bispecific Antibodies vs CAR | Krish Patel, MD | Sarah Cannon Research Institute, Nashville, Tennessee, USA

Oral Abstract | TBD | Speaker | Affiliation